Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 3,985.00
-65.00 (-1.60%)
At close: Aug 21, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 33.02 billion as of August 21, 2026. Its market cap has decreased by -1.00% in one year.
Market Cap
33.02B
Enterprise Value
31.74B
Revenue
647.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,985.00
ChartMarket Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 33.02B, a decrease of -72.14%. That is a compound annual growth rate of -21.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 33.02B | 18.08% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELVAS Healthcare | 61.47B |
| DRGEM | 54.91B |
| QuantaMatrix | 48.83B |
| JPI Healthcare | 45.95B |
| Genoray | 41.51B |
| UXN Co., Ltd. | 31.86B |
| CU Medical Systems | 27.60B |
| MEKICS CO., | 26.04B |